• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非酒精性脂肪肝疾病小鼠的肝脏脂肪酸组成。

Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease.

机构信息

College of Animal Sciences and Veterinary Medicine, Heilongjiang Bayi Agricultural University, Daqing, China.

出版信息

Lipids Health Dis. 2011 Dec 14;10:234. doi: 10.1186/1476-511X-10-234.

DOI:10.1186/1476-511X-10-234
PMID:22165986
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3254603/
Abstract

BACKGROUND

Nonalcoholic fatty liver disease (NAFLD) is one of the most frequent causes of abnormal liver function. Because fatty acids can damage biological membranes, fatty acid accumulation in the liver may be partially responsible for the functional and morphological changes that are observed in nonalcoholic liver disease. The aim of this study was to use gas chromatography-mass spectrometry to evaluate the fatty acid composition of an experimental mouse model of NAFLD induced by high-fat feed and CCl4 and to assess the association between liver fatty acid accumulation and NAFLD. C57BL/6J mice were given high-fat feed for six consecutive weeks to develop experimental NAFLD. Meanwhile, these mice were given subcutaneous injections of a 40% CCl4-vegetable oil mixture twice per week.

RESULTS

A pathological examination found that NAFLD had developed in the C57BL/6J mice. High-fat feed and CCl4 led to significant increases in C14:0, C16:0, C18:0 and C20:3 (P < 0.01), and decreases in C15:0, C18:1, C18:2 and C18:3 (P < 0.01) in the mouse liver. The treatment also led to an increase in SFA and decreases in other fatty acids (UFA, PUFA and MUFA). An increase in the ratio of product/precursor n-6 (C20:4/C18:2) and n-3 ([C20:5+C22:6]/C18:3) and a decrease in the ratio of n-6/n-3 (C20:4/[C20:5+C22:6]) were also observed.

CONCLUSION

These data are consistent with the hypothesis that fatty acids are deranged in mice with non-alcoholic fatty liver injury induced by high-fat feed and CCl4, which may be involved in its pathogenesis and/or progression via an unclear mechanism.

摘要

背景

非酒精性脂肪性肝病(NAFLD)是引起肝功能异常的最常见原因之一。由于脂肪酸会破坏生物膜,因此肝脏中的脂肪酸积累可能部分导致了非酒精性肝病中观察到的功能和形态变化。本研究旨在使用气相色谱-质谱法评估高脂肪饲料和 CCl4 诱导的 NAFLD 实验小鼠模型中的脂肪酸组成,并评估肝内脂肪酸积累与 NAFLD 之间的关系。C57BL/6J 小鼠连续 6 周给予高脂肪饲料以建立实验性 NAFLD。同时,这些小鼠每周接受两次皮下注射 40% CCl4-植物油混合物。

结果

病理检查发现 C57BL/6J 小鼠已发生 NAFLD。高脂肪饲料和 CCl4 导致 C14:0、C16:0、C18:0 和 C20:3 显著增加(P<0.01),C15:0、C18:1、C18:2 和 C18:3 显著减少(P<0.01)。该治疗还导致 SFA 增加,其他脂肪酸(UFA、PUFA 和 MUFA)减少。还观察到产物/前体 n-6(C20:4/C18:2)和 n-3([C20:5+C22:6]/C18:3)的比值增加,n-6/n-3(C20:4/[C20:5+C22:6])的比值降低。

结论

这些数据与假设一致,即高脂肪饲料和 CCl4 诱导的非酒精性脂肪性肝损伤小鼠的脂肪酸紊乱,这可能通过不明机制参与其发病机制和/或进展。

相似文献

1
Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease.非酒精性脂肪肝疾病小鼠的肝脏脂肪酸组成。
Lipids Health Dis. 2011 Dec 14;10:234. doi: 10.1186/1476-511X-10-234.
2
Nrf2 deletion causes "benign" simple steatosis to develop into nonalcoholic steatohepatitis in mice fed a high-fat diet.Nrf2 缺失导致高脂肪饮食喂养的小鼠“良性”单纯性脂肪变性发展为非酒精性脂肪性肝炎。
Lipids Health Dis. 2013 Nov 4;12:165. doi: 10.1186/1476-511X-12-165.
3
Lipidomic profiling of the hepatic esterified fatty acid composition in diet-induced nonalcoholic fatty liver disease in genetically diverse Collaborative Cross mice.饮食诱导的遗传多样性合作杂交小鼠非酒精性脂肪性肝病肝酯化脂肪酸组成的脂质组学分析。
J Nutr Biochem. 2022 Nov;109:109108. doi: 10.1016/j.jnutbio.2022.109108. Epub 2022 Jul 17.
4
Impact of a high-fat diet on the fatty acid composition of the retina.高脂肪饮食对视网膜脂肪酸组成的影响。
Exp Eye Res. 2020 Jul;196:108059. doi: 10.1016/j.exer.2020.108059. Epub 2020 May 5.
5
Time-dependent changes and association between liver free fatty acids, serum lipid profile and histological features in mice model of nonalcoholic fatty liver disease.非酒精性脂肪肝疾病小鼠模型中肝脏游离脂肪酸、血清脂质谱和组织学特征的时变变化及其相关性。
Arch Med Res. 2014 Feb;45(2):116-24. doi: 10.1016/j.arcmed.2013.12.010. Epub 2014 Jan 27.
6
Effect of different dietary supplemental fats and oils on the tissue fatty acid composition and growth of female broilers.不同膳食补充脂肪和油类对雌性肉鸡组织脂肪酸组成及生长的影响。
Br Poult Sci. 1994 Mar;35(1):107-18. doi: 10.1080/00071669408417675.
7
A high-fat diet and multiple administration of carbon tetrachloride induces liver injury and pathological features associated with non-alcoholic steatohepatitis in mice.高脂肪饮食和多次四氯化碳处理可诱导小鼠肝损伤和与非酒精性脂肪性肝炎相关的病理特征。
Clin Exp Pharmacol Physiol. 2013 Jul;40(7):422-30. doi: 10.1111/1440-1681.12102.
8
Characteristics of hepatic fatty acid compositions in patients with nonalcoholic steatohepatitis.非酒精性脂肪性肝炎患者肝脏脂肪酸组成特征。
Liver Int. 2015 Feb;35(2):582-90. doi: 10.1111/liv.12685. Epub 2014 Oct 10.
9
Reduced mitochondrial mass and function add to age-related susceptibility toward diet-induced fatty liver in C57BL/6J mice.线粒体质量和功能的降低增加了C57BL/6J小鼠对饮食诱导的脂肪肝的年龄相关性易感性。
Physiol Rep. 2016 Oct;4(19). doi: 10.14814/phy2.12988.
10
Soluble Fiber Inulin Consumption Limits Alterations of the Gut Microbiota and Hepatic Fatty Acid Metabolism Caused by High-Fat Diet.可溶性膳食纤维菊粉的摄入可限制高脂肪饮食引起的肠道微生物群和肝内脂肪酸代谢的改变。
Nutrients. 2021 Mar 23;13(3):1037. doi: 10.3390/nu13031037.

引用本文的文献

1
Overexpression of (P)RR in SHR and Renin-Induced HepG2 Cells Leads to Spontaneous Hypertension Combined with Metabolic Dysfunction-Associated Fatty Liver Disease.(P)RR在自发性高血压大鼠(SHR)和肾素诱导的HepG2细胞中的过表达导致自发性高血压合并代谢功能障碍相关脂肪性肝病。
Int J Mol Sci. 2025 Jul 7;26(13):6541. doi: 10.3390/ijms26136541.
2
Liver magnetic resonance spectroscopy as an alternative for evaluating Niemann-Pick C disease progression.肝脏磁共振波谱分析作为评估尼曼-匹克C型病进展的一种替代方法。
RSC Adv. 2025 Feb 6;15(6):4079-4085. doi: 10.1039/d4ra06781a.
3
Evaluation of as a Feed Additive in Low-Protein Diets of Broilers.

本文引用的文献

1
Recent insights into hepatic lipid metabolism in non-alcoholic fatty liver disease (NAFLD).非酒精性脂肪性肝病(NAFLD)中肝脏脂质代谢的最新见解。
Prog Lipid Res. 2009 Jan;48(1):1-26. doi: 10.1016/j.plipres.2008.08.001. Epub 2008 Sep 9.
2
Endogenous functions of the aryl hydrocarbon receptor (AHR): intersection of cytochrome P450 1 (CYP1)-metabolized eicosanoids and AHR biology.芳烃受体(AHR)的内源性功能:细胞色素P450 1(CYP1)代谢的类花生酸与AHR生物学的交叉
J Biol Chem. 2008 Dec 26;283(52):36061-5. doi: 10.1074/jbc.R800053200. Epub 2008 Aug 18.
3
Evaluation of blood oxidative stress-related parameters in alcoholic liver disease and non-alcoholic fatty liver disease.
评估某物质作为肉鸡低蛋白日粮中饲料添加剂的效果。 (注:原文中“Evaluation of as a Feed Additive...”表述不完整,这里假设“of”后缺少一个具体物质)
Int J Mol Sci. 2024 Dec 24;26(1):24. doi: 10.3390/ijms26010024.
4
A Comprehensive Analysis of Liver Lipidomics Signature in Adults with Metabolic Dysfunction-Associated Steatohepatitis-A Pilot Study.成人代谢功能障碍相关脂肪性肝炎肝脏脂质组学特征的综合分析——一项初步研究
Int J Mol Sci. 2024 Dec 5;25(23):13067. doi: 10.3390/ijms252313067.
5
3,5-Dimethyl-2,4,6-trimethoxychalcone Lessens Obesity and MAFLD in Leptin-Deficient Mice.3,5-二甲基-2,4,6-三甲氧基查尔酮可减轻瘦素缺乏小鼠的肥胖和 MAFLD。
Int J Mol Sci. 2024 Sep 11;25(18):9838. doi: 10.3390/ijms25189838.
6
Characterization of hepatic fatty acids using magnetic resonance spectroscopy for the assessment of treatment response to metformin in an eNOS mouse model of metabolic nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.采用磁共振波谱技术对肝脏脂肪酸进行特征分析,以评估内皮型一氧化氮合酶(eNOS)小鼠代谢性非酒精性脂肪性肝病/非酒精性脂肪性肝炎模型中二甲双胍治疗反应。
NMR Biomed. 2023 Aug;36(8):e4932. doi: 10.1002/nbm.4932. Epub 2023 Apr 11.
7
Baicalein Prevents Fructose-Induced Hepatic Steatosis in Rats: In the Regulation of Fatty Acid De Novo Synthesis, Fatty Acid Elongation and Fatty Acid Oxidation.黄芩素预防大鼠果糖诱导的肝脂肪变性:在脂肪酸从头合成、脂肪酸延长和脂肪酸氧化的调节方面。
Front Pharmacol. 2022 Jun 30;13:917329. doi: 10.3389/fphar.2022.917329. eCollection 2022.
8
The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population-A Review.宏量营养素在儿童非酒精性脂肪性肝病(NAFLD)发病机制、预防及治疗中的作用——综述
Life (Basel). 2022 Jun 5;12(6):839. doi: 10.3390/life12060839.
9
Intrahepatic fatty acids composition as a biomarker of NAFLD progression from steatosis to NASH by using H-MRS.通过氢磁共振波谱法(H-MRS)检测肝内脂肪酸组成作为非酒精性脂肪性肝病(NAFLD)从单纯性脂肪肝进展为非酒精性脂肪性肝炎(NASH)的生物标志物。
RSC Adv. 2019 Dec 19;9(72):42132-42139. doi: 10.1039/c9ra08914d. eCollection 2019 Dec 18.
10
Changes in the Serum Fatty Acid Profile After Anhepatic Phase of Orthotopic Liver Transplantation Procedure.原位肝移植手术无肝期后血清脂肪酸谱的变化
Front Physiol. 2022 Mar 29;13:817987. doi: 10.3389/fphys.2022.817987. eCollection 2022.
酒精性肝病和非酒精性脂肪性肝病中血液氧化应激相关参数的评估。
Scand J Clin Lab Invest. 2008;68(4):323-34. doi: 10.1080/00365510701673383.
4
Low n-6:n-3 fatty acid ratio, with fish- or flaxseed oil, in a high fat diet improves plasma lipids and beneficially alters tissue fatty acid composition in mice.在高脂肪饮食中,搭配鱼油或亚麻籽油,保持低n-6:n-3脂肪酸比例,可改善小鼠的血脂水平,并有益地改变其组织脂肪酸组成。
Eur J Nutr. 2008 Apr;47(3):153-60. doi: 10.1007/s00394-008-0709-8. Epub 2008 May 3.
5
Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease.非酒精性脂肪性肝病中脂肪酸代谢相关基因表达的重新评估
Int J Mol Med. 2007 Sep;20(3):351-8.
6
A lipidomic analysis of nonalcoholic fatty liver disease.非酒精性脂肪性肝病的脂质组学分析
Hepatology. 2007 Oct;46(4):1081-90. doi: 10.1002/hep.21763.
7
Transcriptional regulation of Bim by FoxO3A mediates hepatocyte lipoapoptosis.FoxO3A对Bim的转录调控介导肝细胞脂肪凋亡。
J Biol Chem. 2007 Sep 14;282(37):27141-27154. doi: 10.1074/jbc.M704391200. Epub 2007 Jul 11.
8
Bifendate treatment attenuates hepatic steatosis in cholesterol/bile salt- and high-fat diet-induced hypercholesterolemia in mice.联苯双酯治疗可减轻胆固醇/胆盐和高脂饮食诱导的小鼠高胆固醇血症中的肝脏脂肪变性。
Eur J Pharmacol. 2006 Dec 15;552(1-3):170-5. doi: 10.1016/j.ejphar.2006.09.011. Epub 2006 Sep 16.
9
Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases.饮食的进化方面、欧米伽-6/欧米伽-3比例与基因变异:对慢性病的营养影响
Biomed Pharmacother. 2006 Nov;60(9):502-7. doi: 10.1016/j.biopha.2006.07.080. Epub 2006 Aug 28.
10
Essential fatty acids: biochemistry, physiology and pathology.必需脂肪酸:生物化学、生理学及病理学
Biotechnol J. 2006 Apr;1(4):420-39. doi: 10.1002/biot.200600012.